中国药业2017，Vol.26Issue(2)：4-7,4.DOI:10.3969/j.issn.1006-4931.2017.02.002
达比加群酯的研究进展
Progress in Research on Dabigatran Etexilat
摘要
Abstract
Dabigatran etexilate is a novel direct oral thrombin inhibitor. The drug has a strong anticoagulant feature, low risk of bleeding, no need for special monitoring, few drug interactions and other advantages and become a hot spot in clinical research. In this paper, the mechanism of action, pharmacokinetics, clinical application and other aspects are reviewed to provide reference for the further research of dabigatran etexilate.关键词
达比加群酯/抗凝/临床研究/进展Key words
dabigatran etexilate/anticoagulation/clinical research/progress分类
医药卫生引用本文复制引用
孟洪光,焦淑清,张立宇,吴连贺..达比加群酯的研究进展[J].中国药业,2017,26(2):4-7,4.基金项目
佳木斯大学研究生科技创新项目[LZR2015023]。 （）
